Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurij Hanzel

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Crohn'S & Colitis|January 12, 2024
Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic ReviewCharlotte Wong, Joep van Oostrom, Valerie Pittet, et al.
Journal of Crohn'S & Colitis|November 7, 2023
Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological OutcomesSéverine Vermeire, Jurij Hanzel, Mark Löwenberg, et al.
Journal of Crohn'S & Colitis|July 26, 2021
Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative ColitisRocio Sedano, Malcolm Hogan, Tran M Nguyen, et al.
Scandinavian Journal of Gastroenterology|July 11, 2018
Success and safety of high infliximab trough levels in inflammatory bowel diseaseDavid Drobne, Tina Kurent, Sasa Golob, et al.
Radiology|August 6, 2024
Reliability of CT Enterography for Describing Fibrostenosing Crohn DiseaseFlorian Rieder, Christopher Ma, Jurij Hanzel, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseasesAdriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2025
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn's Disease Postoperative Recurrence in the PREVENT trialJurij Hanzel, Sudheer K Vuyyuru, Brian Bressler, et al.
Inflammatory Bowel Diseases|November 18, 2021
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's DiseaseJurij Hanzel, Vipul Jairath, Peter De Cruz, et al.
Journal of Crohn'S & Colitis|February 8, 2018
Validation of the 'United Registries for Clinical Assessment and Research' [UR-CARE], a European Online Registry for Clinical Care and Research in Inflammatory Bowel DiseaseJohan Burisch, Javier P Gisbert, Britta Siegmund, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2025
Recommendations to Standardize the Conduct of Clinical Trials Evaluating Novel Therapies for Perianal Fistulizing Crohn's DiseaseSudheer Kumar Vuyyuru, Jurij Hanzel, Mantaj S Brar, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Crohn'S & Colitis|January 12, 2024
Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic ReviewCharlotte Wong, Joep van Oostrom, Valerie Pittet, et al.
Journal of Crohn'S & Colitis|November 7, 2023
Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological OutcomesSéverine Vermeire, Jurij Hanzel, Mark Löwenberg, et al.
Journal of Crohn'S & Colitis|July 26, 2021
Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative ColitisRocio Sedano, Malcolm Hogan, Tran M Nguyen, et al.
Scandinavian Journal of Gastroenterology|July 11, 2018
Success and safety of high infliximab trough levels in inflammatory bowel diseaseDavid Drobne, Tina Kurent, Sasa Golob, et al.
Radiology|August 6, 2024
Reliability of CT Enterography for Describing Fibrostenosing Crohn DiseaseFlorian Rieder, Christopher Ma, Jurij Hanzel, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseasesAdriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2025
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn's Disease Postoperative Recurrence in the PREVENT trialJurij Hanzel, Sudheer K Vuyyuru, Brian Bressler, et al.
Inflammatory Bowel Diseases|November 18, 2021
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's DiseaseJurij Hanzel, Vipul Jairath, Peter De Cruz, et al.
Journal of Crohn'S & Colitis|February 8, 2018
Validation of the 'United Registries for Clinical Assessment and Research' [UR-CARE], a European Online Registry for Clinical Care and Research in Inflammatory Bowel DiseaseJohan Burisch, Javier P Gisbert, Britta Siegmund, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2025
Recommendations to Standardize the Conduct of Clinical Trials Evaluating Novel Therapies for Perianal Fistulizing Crohn's DiseaseSudheer Kumar Vuyyuru, Jurij Hanzel, Mantaj S Brar, et al.
Pageof 5